Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective

Journal of Rheumatology

Volumn 33, Issue 3, 2006, Pages 501-507

  Welsing, Paco M J ^a   Borm, George F ^a   Van Riel, Piet L C M ^a,b  

^a Department of Rheumatology ^*

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Joint damage; Minimal clinically important difference; Rheumatoid arthritis

Indexed keywords

ADULT; AGE; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; EVALUATION; FEMALE; FUNCTIONAL STATUS; HUMAN; JOINT RADIOGRAPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VALIDATION PROCESS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; JOINTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 33644673880     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smolen JS, Kalden JR, Scott DL, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicentre trial. Lancet 1999;353:259-66.
2. Lipsky PE, van der Heijde DMFM, St. Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
3. van der Heijde D, Lassere M, Edmonds J, Kirwan J, Strand V, Boers M. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force. J Rheumatol 2001;28:914-7.
4. Lassere M, Boers M, van der Heijde, Boonen A, Edmonds J, Saudan A, Verhoeven AC. Smallest Detectable Difference in radiological progression. J Rheumatol 1999;26:731-9.
5. Bruynesteyn K, Heijde van der D, Boers M, et al. Minimum Clinically Important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol 2001;28:904-10.
6. Redelmeier DA, Lorig K. Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med 1993;153:1337-42.
7. Wells GA, Tugwell P, Kraag GR, Baker PRA, Groh J, Redelmeier DA. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 1993;20:557-60.
8. Escalante A, del Rincon I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999;42:1712-21.
9. Welsing PMJ, van Gestel AM, Swinkels HL, Kiemeney LALM, van Riel PLCM. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
10. van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
11. Mead R, Pike DJ. A review of response surface methodology from a biometric viewpoint. Biometrics 1975;31:803-51.
12. Bruynesteyn K, van der Heijde D, Bores M, et al. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott Scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 2002;46:913-20.
13. Bruynesteyn K, van der Linden S, Landewe R, Gubler F, Weijers R, van der Heijde D. Progression of rheumatoid arthritis on plain radiographs judged differently by expert radiologists and rheumatologists. J Rheumatol 2004;31:1088-94.
14. Bruynesteyn K, Boers M, Kostense P, van der Linden SJ, van der Heijde D. Deciding on progression of joint damage in paired films individual patients: smallest detectable difference or change? Ann Rheum Dis 2005;64:179-82.
15. Gardiner PV, Sykes HR, Hassey GA, Walker DJ. An evaluation of the health assessment questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol 1993;32:724-8.
16. Scott DL, Coulton BL, Popert AJ. Long term progression of joint damage in rheumatoid arthritis. Ann Rheum Dis 1986;45:373-8.
17. Kuper IH, van Leeuwen MA, van Riel PL, et al. Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease. J Rheumatol 1999;26:268-76.
18. Swinkels HL, Laan RFJM, van 't Hof MA, van der Heijde DMFM, de Vries N, van Riel PLCM. Modified Sharp method: factors influencing reproducibility and validity. Semin Arthritis Rheum 2001;31:176-90.